News

Largest Study of Psychedelic Medicine, with 11,441 Mindbloom Clients, Demonstrates Effectiveness and Safety of Guided At-Home Ketamine Therapy

At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data AUSTIN, Texas, June 14, 2024 /PRNewswire/ — Mindbloom, the leading provider of psychedelic therapy, announced today the […]

No Picture
News

Greenwich LifeSciences Announces $2.5 Million Private Placement

STAFFORD, Texas, June 14, 2024 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company” or “Greenwich”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy […]

[adinserter block="3"]
[adinserter block="3"]
No Picture
News

Return on Conservation™ Report Reveals Texas Conservation Investments Yield 4:1 Financial Returns

AUSTIN, Texas–(BUSINESS WIRE)– #ReturnOnConservation–Texan by Nature (TxN) today announced the results of The Return on Conservation™ Report (ROC™ Report), a groundbreaking analysis confirming that conservation investments in Texas provide substantial financial benefits. The report shows […]

[adinserter block="3"]